{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:01:26Z","timestamp":1762430486699,"version":"build-2065373602"},"reference-count":81,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T00:00:00Z","timestamp":1285804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Cell Division Autoantigen 1 (CDA1) was discovered following screening a human expression library with serum from a patient with Discoid Lupus Erythematosus. CDA1, encoded by TSPYL2 on the X chromosome, shares anti-proliferative and pro\u2011fibrotic properties with TGF-b. It inhibits cell growth through p53, pERK1\/2 and p21\u2011mediated pathways and is implicated in tumorigenesis and the DNA damage response. Its pro-fibrotic property is mediated through cross-talk with TGF-b that results in upregulation of extracellular matrix proteins. The latter properties have identified a key role for CDA1 in diabetes associated atherosclerosis. These dual properties place CDA1 as an attractive molecular target for treating tumors and vascular fibrosis including atherosclerosis and other vascular disorders associated with enhanced TGF-\u03b2 action and tissue scarring.<\/jats:p>","DOI":"10.3390\/genes1030335","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T11:10:35Z","timestamp":1285845035000},"page":"335-348","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and Fibrosis"],"prefix":"10.3390","volume":"1","author":[{"given":"Ban-Hock","family":"Toh","sequence":"first","affiliation":[{"name":"Autoimmunity Laboratory, Centre for Inflammatory Diseases, Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugang","family":"Tu","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zemin","family":"Cao","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglin","family":"Chai","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2010,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinuclear antibodies: Diagnostic markers for autoimmune diseases, probes for cell biology","volume":"44","author":"Tan","year":"1989","journal-title":"Adv. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archderm.1982.01650180046015","article-title":"Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, prognostic examination of 62 patients","volume":"118","author":"Callen","year":"1982","journal-title":"Arch. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nature04254","article-title":"Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin","volume":"438","author":"Hirota","year":"2005","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33665","DOI":"10.1074\/jbc.M007681200","article-title":"SET-related cell division autoantigen-1 (CDA1) arrests cell growth","volume":"276","author":"Chai","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/4315","article-title":"Selection system for genes encoding nuclear-targeted proteins","volume":"16","author":"Ueki","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"ref_6","unstructured":"HGNC: 24358; GeneID: 64061 . Available online: http:\/\/www.genenames.org\/data\/hgnc_data.php?hgnc_id=24358."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1073\/pnas.98.2.629","article-title":"Serological detection of cutaneous T-cell lymphoma-associated antigens","volume":"98","author":"Eichmuller","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/geno.2001.6505","article-title":"Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY\/SET\/NAP-1 superfamily","volume":"73","author":"Ozbun","year":"2001","journal-title":"Genomics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0925-4439(02)00171-0","article-title":"Isolation of differentially expressed genes in human heart tissues","volume":"1588","author":"Sun","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0896-6273(04)00139-4","article-title":"Transcriptional modification by a CASK-interacting nucleosome assembly protein","volume":"42","author":"Wang","year":"2004","journal-title":"Neuron"},{"key":"ref_11","first-page":"3346","article-title":"Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3\u2019 half to different genes: Characterization of the set gene","volume":"12","author":"Wiegant","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0950-3536(11)80049-1","article-title":"Translocation t (6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene","volume":"5","author":"Fornerod","year":"1992","journal-title":"Baillieres Clin. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1074\/jbc.271.19.11059","article-title":"The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A","volume":"271","author":"Li","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/carcin\/bgn087","article-title":"Differentially Expressed Nucleolar TGF-{beta}1 Target (DENTT) exhibits an inhibitory role on tumorigenesis","volume":"29","author":"Kandalaft","year":"2008","journal-title":"Carcinog."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"25204","DOI":"10.1074\/jbc.M402143200","article-title":"A Constitutively Active Arylhydrocarbon Receptor Induces Growth Inhibition of Jurkat T Cells through Changes in the Expression of Genes Related to Apoptosis, Cell Cycle Arrest","volume":"279","author":"Ito","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1371\/journal.ppat.0020105","article-title":"Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth, development","volume":"2","author":"Radke","year":"2006","journal-title":"PLoS Pathog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0960-9822(00)00134-2","article-title":"SH3 domains. Molecular \u2018Velcro\u2019","volume":"4","author":"Morton","year":"1994","journal-title":"Curr. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2443.1996.00258.x","article-title":"SH2, SH3-containing adaptor proteins: Redundant or independent mediators of intracellular signal transduction","volume":"1","author":"Birge","year":"1996","journal-title":"Genes Cells"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.2741\/3053","article-title":"The SH3 domain\u2014a family of versatile peptide-, protein-recognition module","volume":"13","author":"Kaneko","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: Positive, negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(92)90518-H","article-title":"D type cyclins associate with multiple protein kinases, the DNA replication, repair factor PCNA","volume":"71","author":"Xiong","year":"1992","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","article-title":"p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest","volume":"76","author":"Dulic","year":"1994","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","article-title":"The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA","volume":"369","author":"Waga","year":"1994","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0092-8674(94)90186-4","article-title":"Joining the complex: Cyclin-dependent kinase inhibitory proteins, the cell cycle","volume":"79","author":"Peter","year":"1994","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"28623","DOI":"10.1074\/jbc.270.48.28623","article-title":"Functional Analysis of the Transforming Growth Factor beta Responsive Elements in the WAF1\/Cip1\/p21 Promoter","volume":"270","author":"Datto","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cellsig.2005.04.008","article-title":"Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1\/Cip1","volume":"18","author":"Kim","year":"2006","journal-title":"Cell. Signalling"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11722","DOI":"10.1074\/jbc.M609623200","article-title":"Antiproliferative autoantigen CDA1 transcriptionally upregulates p21Wafl\/Cip1 by activating p53, MEK\/ERK1\/2 MAPK pathways","volume":"282","author":"Tu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1101-973","article-title":"HER-2\/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_31","first-page":"1169","article-title":"WAF1\/CIP1 is induced in p53-mediated G1 arrest, apoptosis","volume":"54","author":"Harper","year":"1994","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.10.043","article-title":"A global map of p53 transcription-factor binding sites in the human genome","volume":"124","author":"Wei","year":"2006","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 is required for radiation-induced apoptosis in mouse thymocytes","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35003670","article-title":"p53 sends nucleotides to repair DNA","volume":"404","author":"Lozano","year":"2000","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/35003506","article-title":"A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage","volume":"404","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1016\/S0960-9822(00)00439-5","article-title":"How to activate p53","volume":"10","author":"Caspari","year":"2000","journal-title":"Curr. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1383-5742(00)00035-1","article-title":"Regulation of p53 stability, activity in response to genotoxic stress","volume":"462","author":"Colman","year":"2000","journal-title":"Mutat. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: putting checkpoints in perspective","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent, independent pathways","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19287","DOI":"10.1016\/S0021-9258(17)30656-7","article-title":"Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site","volume":"265","author":"Hertzberg","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_41","first-page":"6404","article-title":"Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I","volume":"48","author":"Gupta","year":"1988","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"35381","DOI":"10.1074\/jbc.274.50.35381","article-title":"The MEK pathway is required for stimulation of p21(WAF1\/CIP1) by transforming growth factor-beta","volume":"274","author":"Hu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_43","first-page":"621","article-title":"Ras-, mitogen-activated protein kinase kinase-dependent, -independent pathways in p21Cip1\/Waf1 induction by fibroblast growth factor-2, platelet-derived growth factor,, transforming growth factor-beta1","volume":"10","author":"Kivinen","year":"1999","journal-title":"Cell Growth Differ."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.abb.2005.09.005","article-title":"Ras\/ERK signaling pathway mediates activation of the p21WAF1 gene promoter in vascular smooth muscle cells by platelet-derived growth factor","volume":"443","author":"Lee","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1006\/bbrc.2000.4215","article-title":"Transcriptional, ERK1\/2-dependent synergistic upregulation of p21(cip1\/waf1) associated with steel factor synergy in MO7e","volume":"280","author":"Lee","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1096\/fasebj.14.1.6","article-title":"Dual specificity phosphatases: A gene family for control of MAP kinase function","volume":"14","author":"Camps","year":"2000","journal-title":"Faseb. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1242\/jcs.03266","article-title":"Diverse physiological functions for dual-specificity MAP kinase phosphatases","volume":"119","author":"Dickinson","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbaexp.2005.02.010","article-title":"Differentially expressed nucleolar TGF-beta1 target (DENTT) shows tissue-specific nuclear, cytoplasmic localization, increases TGF-beta1-responsive transcription in primates","volume":"1728","author":"Ozbun","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/dvdy.10096","article-title":"Expression of differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) in adult mouse tissues","volume":"224","author":"Martinez","year":"2002","journal-title":"Dev. Dyn."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/MCB.16.4.1786","article-title":"Analysis of wild-type, mutant p21WAF-1 gene activities","volume":"16","author":"Lin","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/382325a0","article-title":"Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex","volume":"382","author":"Russo","year":"1996","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/374386a0","article-title":"Separate domains of p21 involved in the inhibition of Cdk kinase, PCNA","volume":"374","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1128\/MCB.16.9.4673","article-title":"Cyclin-binding motifs are essential for the function of p21CIP1","volume":"16","author":"Chen","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/j.1460-2075.1995.tb07031.x","article-title":"Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1\/CIP1\/WAF1","volume":"14","author":"Nakanishi","year":"1995","journal-title":"EMBO J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1101\/gad.8.15.1750","article-title":"p21-containing cyclin kinases exist in both active, inactive states","volume":"8","author":"Zhang","year":"1994","journal-title":"Genes Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1101\/gad.1256504","article-title":"Living with or without cyclins, cyclin-dependent kinases","volume":"18","author":"Sherr","year":"2004","journal-title":"Genes Dev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/gad.11.7.847","article-title":"New functional activities for the p21 family of CDK inhibitors","volume":"11","author":"LaBaer","year":"1997","journal-title":"Genes Dev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/emboj\/18.6.1571","article-title":"The p21(Cip1), p27(Kip1) CDK \u2018inhibitors\u2019 are essential activators of cyclin D-dependent kinases in murine fibroblasts","volume":"18","author":"Cheng","year":"1999","journal-title":"EMBO J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/451903a","article-title":"Cardiovascular disease","volume":"451","author":"Basson","year":"2008","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI119229","article-title":"Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products","volume":"99","author":"Rumble","year":"1997","journal-title":"J. Clin. Invest."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00004872-199816060-00010","article-title":"Angiotensin Converting Enzyme Inhibition, Calcium Antagonism Attenuate Streptozotocin-Diabetes-Associated Mesenteric Vascular Hypertrophy Independently of Their Hypotensive Action","volume":"16","author":"Cao","year":"1998","journal-title":"J. Hypertens."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.CIR.0000021122.63813.32","article-title":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice","volume":"106","author":"Candido","year":"2002","journal-title":"Circulation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.0000124061.78478.94","article-title":"Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis","volume":"109","author":"Candido","year":"2004","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.RES.0000266449.37396.1f","article-title":"Recipes for creating animal models of diabetic cardiovascular disease","volume":"100","author":"Hsueh","year":"2007","journal-title":"Circ. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling, the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000221824.87718.c0","article-title":"Smad3 mediates angiotensin II-, TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot","volume":"98","author":"Sorescu","year":"2006","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00125-009-1555-9","article-title":"Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis","volume":"53","author":"Pham","year":"2010","journal-title":"Diabetologia"},{"key":"ref_68","first-page":"218","article-title":"Arteriogenesis: Angiogenesis within Unstable Atherosclerotic Plaque\u2014 Interactions with Extracellular Matrix","volume":"2","author":"Hayden","year":"2000","journal-title":"Curr. Interv. Cardiol. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2362.2006.01658.x","article-title":"TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC","volume":"36","author":"Schmidt","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","article-title":"Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism","volume":"92","author":"Datto","year":"1995","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/cbir.2001.0832","article-title":"Overexpression of the type II transforming growth factor-beta receptor inhibits fibroblasts proliferation, activates extracellular signal regulated kinase, c-Jun N-terminal kinase","volume":"26","author":"Goldberg","year":"2002","journal-title":"Cell Biol. Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","article-title":"TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"F1657","DOI":"10.1152\/ajprenal.00274.2007","article-title":"Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria","volume":"293","author":"Wang","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-9136(199604)13:4<313::AID-DIA56>3.0.CO;2-7","article-title":"Central role of TGF-beta in the pathogenesis of diabetic nephropathy, macrovascular complications: A hypothesis","volume":"13","author":"Yokoyama","year":"1996","journal-title":"Diabet. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-004-1423-6","article-title":"The time has come to target connective tissue growth factor in diabetic complications","volume":"47","author":"Twigg","year":"2004","journal-title":"Diabetologia"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.RES.0000218782.52610.dc","article-title":"Essential role of Smad3 in angiotensin II-induced vascular fibrosis","volume":"98","author":"Wang","year":"2006","journal-title":"Circ. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1046\/j.1523-1755.2003.00016.x","article-title":"Role of TGF-beta signaling in extracellular matrix production under high glucose conditions","volume":"63","author":"Li","year":"2003","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0092-8674(00)81817-6","article-title":"MADR2 is a substrate of the TGFbeta receptor, its phosphorylation is required for nuclear accumulation, signaling","volume":"87","author":"Abdollah","year":"1996","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1073\/pnas.94.20.10669","article-title":"Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition, transcriptional induction in epithelial cells","volume":"94","author":"Liu","year":"1997","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0002-9440(10)63225-7","article-title":"Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1\/2 MAP kinase signaling pathway","volume":"164","author":"Li","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.02-1117fje","article-title":"Advanced glycation end products activate Smad signaling via TGF-beta-dependent, independent mechanisms: implications for diabetic renal, vascular disease","volume":"18","author":"Li","year":"2004","journal-title":"FASEB J."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/1\/3\/335\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:03:29Z","timestamp":1760220209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/1\/3\/335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,30]]},"references-count":81,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,12]]}},"alternative-id":["genes1030335"],"URL":"https:\/\/doi.org\/10.3390\/genes1030335","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2010,9,30]]}}}